XTX Topco’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Buy |
+4,525
| New | +$2.01M | 0.08% | 329 |
|
|
2025
Q1 | – | Sell |
-2,530
| Closed | -$1.02M | – | 3169 |
|
|
2024
Q4 | $1.02M | Buy |
+2,530
| New | +$1.02M | 0.08% | 284 |
|
|
2024
Q3 | – | Sell |
-8,449
| Closed | -$3.96M | – | 2652 |
|
|
2024
Q2 | $3.96M | Buy |
+8,449
| New | +$3.96M | 0.34% | 19 |
|
|
2024
Q1 | – | Sell |
-2,718
| Closed | -$1.11M | – | 2368 |
|
|
2023
Q4 | $1.11M | Sell |
2,718
-4,351
| -62% | -$1.77M | 0.24% | 24 |
|
|
2023
Q3 | $2.46M | Buy |
7,069
+4,270
| +153% | +$1.48M | 0.42% | 8 |
|
|
2023
Q2 | $985K | Buy |
2,799
+1,170
| +72% | +$412K | 0.18% | 90 |
|
|
2023
Q1 | $513K | Buy |
1,629
+774
| +91% | +$244K | 0.11% | 276 |
|
|
2022
Q4 | $247K | Sell |
855
-1,054
| -55% | -$304K | 0.05% | 709 |
|
|
2022
Q3 | $553K | Buy |
1,909
+967
| +103% | +$280K | 0.14% | 206 |
|
|
2022
Q2 | $265K | Sell |
942
-1,239
| -57% | -$349K | 0.11% | 324 |
|
|
2022
Q1 | $569K | Sell |
2,181
-1,073
| -33% | -$280K | 0.25% | 113 |
|
|
2021
Q4 | $715K | Buy |
+3,254
| New | +$715K | 0.4% | 38 |
|